Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ONCE

Spark Therapeutics (ONCE) Stock Price, News & Analysis

Spark Therapeutics logo

About Spark Therapeutics Stock (NASDAQ:ONCE)

Key Stats

Today's Range
$0.18
$0.18
50-Day Range
$110.05
$113.57
52-Week Range
$34.53
$114.20
Volume
N/A
Average Volume
891,560 shs
Market Capitalization
$6.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONCE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spark Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ONCE Stock News Headlines

This dark force is about to change everything
An unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and live. Porter Stansberry calls it The Final Displacement — a rare turning point that’s only happened four times in human history, each one redefining entire eras. His new documentary reveals why this shift could trigger both immense loss and unprecedented opportunity, and what you can do to prepare before it accelerates.tc pixel
See More Headlines

ONCE Stock Analysis - Frequently Asked Questions

Spark Therapeutics Inc (NASDAQ:ONCE) announced its quarterly earnings data on Tuesday, August, 7th. The biotechnology company reported ($0.77) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.43) by $0.34. The biotechnology company earned $25.19 million during the quarter, compared to analysts' expectations of $29.44 million. Spark Therapeutics had a negative net margin of 358.41% and a negative trailing twelve-month return on equity of 59.10%.

Spark Therapeutics (ONCE) raised $88 million in an initial public offering on Friday, January 30th 2015. The company issued 5,500,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Credit Suisse acted as the underwriters for the IPO and Cowen and Company and Sanford C. Bernstein were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Spark Therapeutics investors own include Bristol Myers Squibb (BMY), NVIDIA (NVDA), Brainstorm Cell Therapeutics (BCLI), Meta Platforms (META), Alibaba Group (BABA), Gilead Sciences (GILD) and Micron Technology (MU).

Company Calendar

Last Earnings
8/07/2018
Today
10/22/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ONCE
CIK
1609351
Fax
N/A
Employees
368
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$78.82 million
Net Margins
-358.41%
Pretax Margin
N/A
Return on Equity
-59.10%
Return on Assets
-33.13%

Debt

Debt-to-Equity Ratio
0.35
Current Ratio
4.67
Quick Ratio
4.35

Sales & Book Value

Annual Sales
$64.72 million
Price / Sales
0.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$13.15 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
38,523,000
Free Float
N/A
Market Cap
$6.94 million
Optionable
No Data
Beta
2.05
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ONCE) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners